VHA Selects Clinical Xpert from Thomson Reuters as its Preferred Solution for Mobile Clinical Improvement Systems
ANN ARBOR, Mich., March 2 /PRNewswire/ -- The Healthcare business of Thomson Reuters has been selected by VHA Inc., the national healthcare alliance, as its preferred vendor for mobile clinical quality improvement solutions.
With this preferred vendor designation, Thomson Reuters is autho...
Thomson Reuters Installs Clinical Xpert at Catholic Healthcare West for HIS Downtime Solution
ANN ARBOR, Mich., Jan. 28 /PRNewswire/ -- Thomson Reuters announced today
that Catholic Healthcare West (CHW), the eighth largest hospital system in the
United States, has implemented Clinical Xpert(TM) as its downtime solution
when access to the hospital information system (HIS) and electroni...
Clinical Xpert Navigator From Thomson Reuters Is Named Best Mobile Data System in the KLAS Awards - for Seventh Consecutive Year
ANN ARBOR, Mich., Jan. 7 /PRNewswire/ -- The Healthcare business of
Thomson Reuters announced today that its Clinical Xpert(TM) Navigator has been
named the Category Leader for Mobile Data Systems in the latest "Top 20 Best
in KLAS Awards: Software & Professional Services" report.
T...
The Peer Group Launches Xpert Xchange(SM), an Innovation in Medical Peer Influence Programs
EDISON, N.J., July 7 /PRNewswire/ -- The Peer Group, a leading provider
of peer-to-peer medical forums for the bio-pharmaceutical industry, and an
Informed Medical Communications (IMC) company, today announced the launch
of
Xpert Xchange(SM).
Xpert Xchange is the newest innovation in moderated...
Thomson Healthcare's Clinical Xpert Navigator Tops KLAS Annual Performance Ranking in Mobile Data Systems for Sixth Consecutive Year
STAMFORD, Conn., Feb. 12 /PRNewswire/ -- Thomson Healthcare, the
leading provider of integrated decision support solutions that assist
healthcare organizations in their efforts to improve clinical and business
performance, announced that its Clinical
Xpert Navigator solution has been
recognize...
Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA
Broadlane Members Include Hospital Systems Such as Tenet and Kaiser
SUNNYVALE, Calif., Nov. 29 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq:
CPHD) today announced it signed a group purchasing contract with Broadlane,
a leading supply chain services company serving more than 20,000 acute care
ho...
Weight-Loss Medication Evaluated By Nutrition Expert
A 60 mg low-dose version of the prescription weight-loss medication orlistat (marketed by GlaxoSmithKline as Xenical? 120 mg) was found to be safe, effective and tolerable in overweight individuals,// according to new data presented today at the 2005 Annual Meeting of NAASO, The Obesity Society in ...
Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection
...auses Clostridium difficile infection (CDI). The
xpert C. difficile test is the first test for CDI to d...of rapid and accurate HAI tests on the market. The
xpert C. difficile test establishes new levels of spee...urate diagnostic tests. Our novel approach for the
xpert C. difficile test, as measured against the true ...
Cepheid Announces European Release of Improved Test for BCR-ABL Chromosomal Translocation Associated With Chronic Myelogenous Leukemia (CML)
...y announced test for Mycobacterium tuberculosis ,
xpert BCR-ABL Monitor uses nested PCR, a critical amplif...ed as often as four times a year.
"Cepheid's
xpert BCR-ABL Monitor test is a powerful tool for monito...ho may be at risk for relapse."
The improved
xpert BCR-ABL Monitor test highlights the broad market a...
Cepheid Receives Health Canada License for Xpert(R) HemosIL(R) FII & FV Test
...as issued Cepheid a medical device license for its
xpert HemosIL FII & FV test. The test detects Factor...ia, an increased risk of blood clots (thrombosis).
xpert HemosIL FII & FV delivers results in just over... (IL), the exclusive worldwide distributor for the
xpert HemosIL FII & FV test.
"Given the comple...
Instrumentation Laboratory Wins Patent Infringement and Unfair Competition Trial Against Diagnostica Stago Relating to Reagents for Hemostasis Diagnostics
...gnosis of thrombophilia, including antithrombin, protein C, protein S, activated protein C resistance, factor V Leiden, homocysteine, ThromboPath, and
xpert HemosIL FII & FV molecular. Additionally, HemosIL reagents are available for the management of antiphospholipid syndrome, coagulation factors, von...
Cepheid Announces European Release of First On-Demand Molecular Pre-Surgical Screening Test for Simultaneous Detection of Methicillin-Sensitive and Resistant S. aureus
...ive Staphylococcus aureus in less than one hour.
xpert MRSA/SA Nasal is Cepheid's tenth CE IVD test for u...cular testing platform.
"With the addition of
xpert MRSA/SA Nasal, Cepheid now offers European clinici...rgical site infections (SSIs). Cepheid's on-demand
xpert MRSA/SA Nasal test provides rapid determination of...
Cepheid Receives Health Canada License for First On-demand Diagnostic Test for Life-threatening MRSA and S. aureus Infections From Patient Positive Blood Culture Bottles
...results reporting in less than one hour, Cepheid's
xpert MRSA/SA BC test was designed to empower physicians...e Commercial Operations. "With the addition of our
xpert MRSA/SA Blood Culture diagnostic test, Canadian in... overall management of infections."
Cepheid's
xpert MRSA/SA BC test processes positive blood culture s...
Cepheid Reports Fourth Quarter and Full Year 2008 Results
...icer. "Full year growth of more than 400% for our
xpert MRSA test positions us as the leader in molecular ...of our Clostridium difficile test, our vanA/vanB
xpert test for vancomycin-resistant enterococci (or VRE)...of the year, we expect the European release of our
xpert TB test which simultaneously detects TB along with...
Tomball Regional Medical Center Selects Clinical Xpert(TM) from Thomson Reuters to Lead Quality Improvement Initiatives
...5 /PRNewswire/ -- Tomball Regional Medical Center
has selected the Clinical
xpert suite of products (formerly MercuryMD MData)
from the Healthcare business o...y and clinical
decision-making.
The medical center will use Clinical
xpert CareFocus(TM)
( http://clinical.thomsonhealthcare.com/products/CXCareFocus/...
Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections
...n and soft
tissue infections. Availability of the
xpert MRSA/SA SSTI test is expected to
empower Canadian ...nagement.
In less than one hour, Cepheid's
xpert MRSA/SA SSTI test processes
specimens from suspect...r 1,000 hospital admissions across Canada.
xpert MRSA/SA SSTI is Cepheid's fifth test to receive a ...
Parrish Medical Center Deploys Clinical Xpert(TM) Solutions from Thomson Reuters
...lemented Clinical
Xpert CareFocus(TM) and Clinical
xpert Navigator which are both part of the
Clinical
xpert suite of workflow solutions from the Healthcare bu... throughout the continuum of care.
"The Clinical
xpert CareFocus and Navigator solutions are helping
Parr...
St. Peter's Hospital of Albany Improves Core Measures Processes
...ovement program, St. Peter's implemented the Clinical Xpert(TM)
CareFocus(TM) solution from Thomson Reuters.
CareFocus, an extension of the Clinical
xpert Navigator solution, gives
clinicians access to patient data via Palm, Windows Mobile, and
BlackBerry(R) smartphones as well as through a Web portal. C...
Cepheid Signs Group Purchasing Contract With Premier Healthcare Alliance, One of the Largest U.S. Group Purchasing Organizations
...ection rates have increased every year since
1970.
xpert MRSA test results are currently available in appro...test
results to the floor. The availability of the
xpert MRSA test and the
GeneXpert System is expected to ...r HAI rates and
improved patient care.
On-demand
xpert MRSA results enable healthcare professionals to ra...
Cepheid Reports Record Revenue of $44.8 Million
...st utilization in the emerging
HAI test market for
xpert MRSA, continued adoption of the GeneXpert System
a...now represent 61 percent of total product revenue.
xpert MRSA
test revenue grew 78 percent sequentially fro...d, the Company filed a 510(k) with the FDA for the
xpert MRSA/SA --
SSTI (Skin and Soft Tissue Infection) p...
Cepheid Selected as Vendor of Choice by Connecticut Hospital Association Shared Services Program for Molecular MRSA Surveillance Testing
...exclusively market Cepheid's
GeneXpert Systems and
xpert MRSA test kits to up to 164 of its acute care
memb...ing
cause of death among all HAIs. Cepheid markets
xpert MRSA, a molecular test
that runs on the GeneXpert ... doesn't
require highly-skilled labor.
On-demand
xpert MRSA results enables healthcare professionals to
r...